tellimagrandin ii has been researched along with 3,4,5-trihydroxybenzaldehyde in 1 studies
| Studies (tellimagrandin ii) | Trials (tellimagrandin ii) | Recent Studies (post-2010) (tellimagrandin ii) | Studies (3,4,5-trihydroxybenzaldehyde) | Trials (3,4,5-trihydroxybenzaldehyde) | Recent Studies (post-2010) (3,4,5-trihydroxybenzaldehyde) |
|---|---|---|---|---|---|
| 10 | 0 | 4 | 6 | 0 | 4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, L; Feng, Z; Huang, W; Huang, Y; Mei, Z; Tao, W; Wang, K; Zhou, H | 1 |
1 other study(ies) available for tellimagrandin ii and 3,4,5-trihydroxybenzaldehyde
| Article | Year |
|---|---|
Protection of the Geum japonicum Thunb. var. chinense extracts against oxygen-glucose deprivation and re-oxygenation induced astrocytes injury via BDNF/PI3K/Akt/CREB pathway.
Topics: Animals; Apoptosis; Astrocytes; Benzaldehydes; Gallic Acid; Geum; Glucosides; Neuroprotective Agents; Plant Extracts; Rats; Reperfusion Injury; Signal Transduction | 2020 |